pioglitazone has been researched along with Arterial Inflammation in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamblin, M | 1 |
| Chang, L | 1 |
| Zhang, H | 1 |
| Yang, K | 1 |
| Zhang, J | 1 |
| Chen, YE | 1 |
1 other study available for pioglitazone and Arterial Inflammation
| Article | Year |
|---|---|
Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ mediates pioglitazone-reduced vascular lesion formation.
Topics: Animals; Arteritis; Carotid Arteries; Cell Adhesion; Mice; Mice, Inbred CBA; Mice, Knockout; Mice, T | 2011 |